1.89
-0.04 (-1.82%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Agricultural Inputs (US) | Mixed | Mixed |
| Agricultural Inputs (Global) | Mixed | Mixed | |
| Stock | Nexentis Technologies Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -4.0 |
| Average | -1.50 |
|
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology. |
|
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| Investment Style | Small Value |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 31 Mar 2026 | 0 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |